Anixa Share Price

Anixa Share Price

NASDAQ: ANIX | Micro Cap | Healthcare
$2.69
+$0.02 (0.56%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Anixa Stock Performance

Open
$2.74
Prev. Close
$2.67
Circuit Range
N/A
Day Range
$2.68 - $2.78
Year Range
$2.37 - $5.43
Volume
6,236
Average Traded
$2.72

Anixa Share Price Today

As of 19 November 2026, Anixa Biosciences, Inc.'s share price is $2.69. The stock opened at $2.74, compared to its previous close of $2.67. During today's trading session, Anixa Biosciences, Inc.'s share price traded between $2.68 and $2.78, with an average price of $2.73. Over the past 52 weeks, the stock has recorded a high of $5.43 and a low of $2.37. In terms of performance, Anixa Biosciences, Inc.'s share price has declined by 1.65% over the last six months and is down 41.44% on a year-on-year basis.

Anixa Share Price Chart

Line chart of the Anixa price trend over the selected period. The price rose overall, ranging from 2.68 to 2.81, ending at 2.69.
$2.68$2.78
L
Show Current Price
H

Anixa Stock Fundamentals & Key Indicators

Market Cap
$87138.99
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.30
Revenue (TTM)
$0.00
Return On Equity (TTM)
-71.74%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
3.33%

Anixa Quarterly Profit & Loss

All figures in USD

ParticularsOct 2025Jan 2026Apr 2026Jul 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.70-$2.57-$2.52-$2.61
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A4.81%1.95%-3.57%

Anixa Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.21$0.00$0.00
Net Profit-$13.60-$9.81-$12.55-$10.93
Net Profit MarginN/A-4671.43%N/AN/A
Income ChangeN/A27.87%-27.93%12.91%

Anixa Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.190.230.170.21
Current Assets15.8921.3625.3630.2
Total Assets16.0821.5925.5230.41
Non Current Liabilities0.160.20.120.18
Current Liabilities1.972.52.032.04
Total Liabilities2.132.72.152.21
Shareholders' Equity13.9518.8923.3728.2

Anixa Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-7.17-7.34-6.21-6.49
Investing4.874.28-5.6-10.73
Financing2.283.420.370.45

About Anixa

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Anixa Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.10
$2.69
-14.22%
Oct 2026
$2.90
$3.13
+7.19%
Sep 2026
$3.33
$2.92
-19.11%
Aug 2026
$3.45
$3.61
+4.79%
Jul 2026
$2.81
$3.44
+21.52%
Jun 2026
$2.70
$2.83
+3.85%
May 2026
$2.99
$2.73
-7.61%
Apr 2026
$2.76
$2.96
+13.22%
Mar 2026
$2.94
$2.61
-12.12%
Feb 2026
$3.02
$2.97
-2.14%
Jan 2026
$3.17
$3.04
-1.46%
Dec 2025
$4.54
$3.08
-32.82%

Anixa Share Price FAQs